DNA segment encoding a gene for a receptor related to the epidermal growth factor receptor
AssigneeUnited States of America
InventorsMatthias H. Kraus, Stuart A. Aaronson
Life of this patent
Estimating the term…
Loading patent…
AssigneeUnited States of America
InventorsMatthias H. Kraus, Stuart A. Aaronson
Estimating the term…
A DNA fragment distinct from the epidermal growth factor receptor (EGF-R) and erbB-2 genes was detected by reduced stringency hybridization of v-erbB to normal genomic human DNA. Characterization of the cloned DNA fragment mapped the region of v-erbB homology to three exons with closest homology of 64% and 67% to a contiguous region within the tyrosine kinase domains of the EGF-R and erbB-2 proteins, respectively. cDNA cloning revealed a predicted 148 kd transmembrane polypeptide with structural features identifying it as a member of the erbB family, prompting designation of the new gene as erbB-3. It was mapped to human chromosome 12q11-13 and was shown to be expressed as a 6.2 kb transcript in a variety of normal tissues of epithelial origin. Markedly elevated erbB-3 mRNA levels were demonstrated in certain human mammary tumor cell lines. These findings indicate that increased erbB-3 expression, as in the case of EGF-R and erbB-2, plays a role in some human malignancies.
A DNA isolate consisting essentially of the nucleotide sequence of an erbB-3 gene defined in FIG. 4.
A DNA isolate consisting essentially of the nucleotide sequence of a genomic DNA fragment capable of being produced by cleavage with the SacI restriction enzyme, having a size of about 9 kb and being detectable by nucleic acid hybridization with a probe derived from the v-erbB gene under reduced hybridization stringency conditions, wherein said isolate is the human genomic DNA clone E3-1 having the partial restriction enzyme map defined in FIG. 2 and the partial DNA sequence defined in FIG. 3.
A DNA isolate consisting essentially of a portion of the nucleotide sequence as defined in FIG. 4 that encodes a portion of erbB-3 protein sufficient to provide an erbB-3 receptor protein binding site for an antibody thereto which is further characterized by not binding to erbB-2 or erbB receptor protein.
Dependencies are inferred from the claim text.